[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2142407T3 - Antimalaria. - Google Patents

Antimalaria.

Info

Publication number
ES2142407T3
ES2142407T3 ES94927070T ES94927070T ES2142407T3 ES 2142407 T3 ES2142407 T3 ES 2142407T3 ES 94927070 T ES94927070 T ES 94927070T ES 94927070 T ES94927070 T ES 94927070T ES 2142407 T3 ES2142407 T3 ES 2142407T3
Authority
ES
Spain
Prior art keywords
antimalaria
antimalary
quinine
compound
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94927070T
Other languages
English (en)
Inventor
Ivan Havlik
Yutaro Kaneko
Tohru Mimura
Goro Chihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of ES2142407T3 publication Critical patent/ES2142407T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/49—Cinchonan derivatives, e.g. quinine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

SE PRESENTA UN NUEVO COMPUESTO ANTIMALARIA QUE CONTIENE UN POLISACARIDO SULFATADO O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DEL MISMO SOLO O JUNTO CON QUININA COMO INGREDIENTE ACTIVO Y QUE TIENE UN ALTO EFECTO TERAPEUTICO.
ES94927070T 1993-09-20 1994-09-20 Antimalaria. Expired - Lifetime ES2142407T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23329693 1993-09-20

Publications (1)

Publication Number Publication Date
ES2142407T3 true ES2142407T3 (es) 2000-04-16

Family

ID=16952886

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94927070T Expired - Lifetime ES2142407T3 (es) 1993-09-20 1994-09-20 Antimalaria.

Country Status (9)

Country Link
US (1) US5780452A (es)
EP (1) EP0676206B1 (es)
JP (1) JP3718849B2 (es)
CA (1) CA2148607A1 (es)
CZ (1) CZ128095A3 (es)
DE (1) DE69422496T2 (es)
ES (1) ES2142407T3 (es)
OA (1) OA10157A (es)
WO (1) WO1995008334A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2414320C (en) 2000-06-30 2008-04-01 Polydex Pharmaceuticals Limited Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
EP1552823A3 (en) * 2000-06-30 2005-09-21 Polydex Pharmaceuticals Limited Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
EP1329452A1 (en) * 2000-10-20 2003-07-23 Ajinomoto Co., Inc. Medicinal compositions, dose and method for treating malaria
FR2998176B1 (fr) * 2012-11-16 2015-01-16 Univ Blaise Pascal Clermont Ii Composition de polysaccharide sulfate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1129148B (de) * 1960-10-19 1962-05-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von Heparin-Derivaten zytostatisch wirkender Stoffe
GB1227830A (es) * 1968-07-18 1971-04-07
US4197643A (en) * 1978-03-14 1980-04-15 University Of Connecticut Orthodontic appliance of titanium alloy
DE3601136A1 (de) * 1986-01-16 1987-07-23 Max Planck Gesellschaft Hemmstoffe der reversen transkriptase fuer prophylaxe und therapie von retrovirus-infektionen in saeugetieren
US4807177A (en) * 1986-06-06 1989-02-21 Ward Richard J Multiple format hand held label printer
US5512672A (en) * 1988-07-07 1996-04-30 Ajinomoto Co., Inc. Curdlan sulfate
JPH0725802B2 (ja) * 1988-11-28 1995-03-22 味の素株式会社 カードランまたはレンチナンの硫酸エステルまたはその塩の製造方法
JPH03218317A (ja) * 1988-12-06 1991-09-25 Japan Found Cancer Res 抗レトロウイルス剤
JP2772813B2 (ja) * 1989-03-03 1998-07-09 サッポロビール株式会社 抗ウイルス作用と免疫賦活作用を有する組成物
SE9003181D0 (sv) * 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction

Also Published As

Publication number Publication date
CZ128095A3 (en) 1995-10-18
EP0676206A4 (es) 1995-10-25
CA2148607A1 (en) 1995-03-30
EP0676206B1 (en) 2000-01-05
EP0676206A1 (en) 1995-10-11
DE69422496T2 (de) 2002-07-11
WO1995008334A1 (fr) 1995-03-30
JP3718849B2 (ja) 2005-11-24
OA10157A (en) 1996-12-18
DE69422496D1 (de) 2000-02-10
US5780452A (en) 1998-07-14

Similar Documents

Publication Publication Date Title
ES2171416T3 (es) Remedio contra la trombocitopenia.
CL2008003938A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden de estres postraumatico (divisional sol. 1799-00).
AR027391A1 (es) Composiciones farmaceuticas de toxina botulinica
ES2103563T3 (es) Esteres nitricos con una actividad farmacologica y procedimiento para su preparacion.
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
BR0015605A (pt) Composição e uso
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
ES2082288T3 (es) Composiciones terapeuticas para administracion intranasal de ketorolaco.
AR004179A1 (es) Sales de (endo,sin)-(-)-3-(3-hidroxi-1-oxo-2-fenilpropoxi)-8-metil-8-(1- metiletil)-8-azoniabiciclo[3.2.1] octano y preparaciones medicamentosasinhalativas que las contienen.
CO4950529A1 (es) Dihidropirimidinas y productos que las contienen
NZ324887A (en) Piperazine and piperidine compounds with analgesic effect
ATE216220T1 (de) Osmotische darreichungsform mit zwei mantelschichten
GT199800126A (es) Terapia de combinacion.
ES2093735T3 (es) Derivados de melatonina para uso en la terapia de trastornos del sueño y en medicacion preanestesica.
ES2192234T3 (es) Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos.
PA8451701A1 (es) Formulacion inyectable transparente de compuesto anestesico
DE69531098D1 (de) Piperidine und pyrrolidine
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
AR012217A1 (es) Una composicion topica para mejorar la penetracion de compuestos farmaceuticos
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
ES2142407T3 (es) Antimalaria.
CO4940448A1 (es) Modificacion a cristal de una sustancia de medicamento
ES2195040T3 (es) Conjugado que incluye un principio activo, un polipeptido y varios polieteres y su uso como medicamento.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 676206

Country of ref document: ES